retatrutide ly3437943 glp-1 gip glucagon receptor agonist in healthy participants in a phase 1 single ascending dose Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6



























